Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Exercise therapy for human immunodeficiency virus/AIDS patients: Guidelines for clinical exercise therapists.

Grace JM, Semple SJ, Combrink S.

J Exerc Sci Fit. 2015 Jun;13(1):49-56. doi: 10.1016/j.jesf.2014.10.003. Epub 2015 Jan 29. Review.

2.

Characterization of the naturally occurring Arg344His variant of the human 5-HT 3A receptor.

Combrink S, Kostanian A, Walstab J, Barann M, Brüss M, Göthert M, Bönisch H.

Pharmacol Rep. 2009 Sep-Oct;61(5):785-97.

3.

Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization.

Walstab J, Combrink S, Brüss M, Göthert M, Niesler B, Bönisch H.

Anal Biochem. 2007 Sep 15;368(2):185-92. Epub 2007 Jun 8.

PMID:
17617370
4.

Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E.

Niesler B, Walstab J, Combrink S, Möller D, Kapeller J, Rietdorf J, Bönisch H, Göthert M, Rappold G, Brüss M.

Mol Pharmacol. 2007 Jul;72(1):8-17. Epub 2007 Mar 28.

PMID:
17392525
5.

Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.

Kurzwelly D, Barann M, Kostanian A, Combrink S, Bönisch H, Göthert M, Brüss M.

Pharmacogenetics. 2004 Mar;14(3):165-72.

PMID:
15167704

Supplemental Content

Loading ...
Support Center